STUB1 and breast cancer: We reported that the novel agent, 2‐(4‐hydroxy‐3‐methoxyphenyl)‐benzothiazole (YL‐109) induced CHIP transcription and inhibited breast cancer cell growth and invasiveness in vitro 35.